Drug intelligence / Profile preview

TRIFECTO

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

TRIFECTO is a veterinary combination drug available in Australia, primarily used for the treatment and control of internal parasites in animals. It contains four active pharmaceutical ingredients—abamectin, levamisole hydrochloride (a derivative of levamisole), oxfendazole, cobalt, and sodium selenite. Abamectin is an avermectin class antiparasitic that acts by binding to glutamate-gated chloride channels in nerve and muscle cells of parasites, causing paralysis and death. Levamisole is an imidazothiazole-class anthelmintic that works as a nicotinic acetylcholine receptor agonist at the neuromuscular junctions of nematodes, leading to paralysis. Oxfendazole is a benzimidazole-class broad-spectrum anthelmintic that inhibits microtubule polymerization by binding to beta-tubulin in parasitic worms. Cobalt and sodium selenite are trace minerals included as nutritional supplements to support animal health[1]. This product appears to be intended for veterinary use only.

Brand names
TRIFECTO
Other names
Trifecto
02

Targets

TUBB (Tubulin (alpha and beta subunits))GluCl (Glutamate-gated chloride channel)Nicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on TRIFECTO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRIFECTO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call